Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016-2017.
David Phillip SerotaTyler S BartholomewHansel E TookesPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
While opioid use contributed to most IDU-associated infections, many hospitalizations also involved stimulants. Increasing access to harm reduction interventions could help prevent these infections, while further research on the acute management of stimulant use disorder-associated infections is needed.